Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 411 results found. Search for [ Serum Institute of India vaccine trials ]

Results 1 to 21 of 411
BusinessToday.In
May 16, 2021
Russian Ambassador to India Nikolay Kudashev termed the delivery of the second consignment of Sputnik V vaccine in the country \"very timely\"


Shailendra Shukla
New Delhi, May 15, 2021
Extension of gap between Covishield doses 'reasonable approach', says Dr FauciAmid the furore over the extension of the gap between two doses of Covishield, White House chief medical adviser Dr Anthony Fauci said that it is a 'reasonable approach'. He said that if one is in a situation that India finds itself in currently, then one would have to try and figure out other ways to get as many as possible vaccinated. The comments come after the government announced on Thursday that the gap betwe...


BusinessToday.In
May 13, 2021
Bharat Biotech has been producing Covaxin at its Biosafety Level-3 (BSL-3) facilities in Hyderabad and Bengaluru, where production capacity had been enhanced in a step-wise manner


BusinessToday.In
May 13, 2021
Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers


BusinessToday.In
New Delhi, May 12, 2021
Prime Minister Narendra Modi will not travel to the UK to attend the G-7 summit in June due to the coronavirus situation in the country; To strengthen corporate governance practices and disclosure requirements, Sebi has notified new rules, including that top 1,000 listed firms will have to formulate a dividend distribution policy; Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. Watch this and more news on News Blast. BT podcast : 'Outright lies', says China on reports of weaponising COVID-19 in 2015


Rashi Bisaria
New Delhi, May 12, 2021
'Outright lies': China on reports that its military scientists probed weaponising COVID-19 in 2015China on Monday termed as \"outright lies\", the media reports that its military scientists investigated weaponising coronaviruses five years before the COVID-19 pandemic outbreak and said it is an attempt by the US to smear the country. The US State Department reportedly obtained the \"bombshell\" documents, which were written by Chinese military scientists and senior public health officials in ...


PTI
May 9, 2021
Tata Sons President (Infrastructure, Defence, Aerospace and Global Corporate Affairs) Banmali Agrawala said people need to be vaccinated faster but safely as well


PTI
May 8, 2021
While WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen vaccines for emergency use, the Chinese vaccine got delayed recognition due to data related issues


Vivek Dubey
May 6, 2021
\"The cost of the Sputnik Light vaccine globally will be less than $10 [around Rs 730], while it has simple storage requirements, at 2-8 degrees Celsius, which provide for easy logistics\"


PTI
May 4, 2021
The investments confirmed by Downing Street on Monday evening form part of an Enhanced Trade Partnership (ETP), which will set the ambition to double the value of UK-India trade by 2030


BusinessToday.In
May 4, 2021
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK


PTI
May 4, 2021
The investments confirmed by Downing Street form part of an Enhanced Trade Partnership (ETP), which UK PM Boris Johnson and his Indian counterpart Narendra Modi will formally sign off during their talks


PB Jayakumar
April 26, 2021
World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage


BusinessToday.In
April 22, 2021
If the coronavirus vaccine developed by Biological E gets emergency authorisation, it will be the fourth vaccine against coronavirus in India


BusinessToday.In
April 21, 2021
Coronavirus in India: Vaccine manufacturers have also urged the government to price vaccine doses at rates that are globally competitive


Vidya
April 20, 2021
The court order noted that union government had rolled out an extensive vaccination drive and, as on March 16, 66 million doses of Covishield have been supplied to the Centre


PTI
April 20, 2021
The company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application


Ashutosh Kumar
April 19, 2021
The government will make pre-payment to both Serum Institute of India and Bharat Biotech for the vaccine supply. \"This will serve as an incentive to the two vaccine suppliers,\" said a source


PTI
April 18, 2021
India is battling a massive surge in COVID-19 cases and health ministry data updated on Sunday showed that a record single-day rise of 2,61,500 coronavirus infections has taken the country's total tally to 1,47,88,109


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PAGES 1 OF 21  12345